Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has amended its company constitution, ...

Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Grant documents that detailed creating the virus that causes COVID-19 may have been concealed, leading to a “flawed” probe of ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

*仅供医学专业人士阅读参考APOE4是阿尔茨海默病（AD）的最强遗传风险因素，降低AD发病年龄，促进AD的典型病理，包括β-淀粉样蛋白（Aβ）和过度磷酸化的tau蛋白（p-tau）沉积。APOE4在AD发病机制中的作用十分复杂，仍没有被完全揭示。星形 ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics made significant strides in its cell therapy programs, enrolling the first patient in its CHM CDH17 Phase 1/2 ...

CAR T-cell therapy (Chimeric Antigen Receptor T-cell therapy) is one of the most remarkable breakthroughs in this domain, ...

通过VOS viewer软件进行关键词共现分析得出，多黏菌素B的抗菌机制、微生物耐药性机制与检测、多黏菌素B的药代动力学、多黏菌素B的临床应用尤其是脓毒症的临床应用为近年研究热点。WOS ...

In a report released today, Asthika Goonewardene from Truist Financial assigned a Buy rating to Legend Biotech (LEGN – Research Report).